Umbilical cord blood transplantation: Current status and future directions

Current Opinion in Organ Transplantation

Volumn 8, Issue 1, 2003, Pages 109-117

  Sanz, Guillermo F ^a   Rocha, Vanderson ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1642632122     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/00075200-200303000-00020     Document Type: Review

References (65)

1. Gluckman E, Broxmeyer HE, Auerbach AD, et al.: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
2. Wernet P: The Netcord inventory and use [Netcord web site]. July 12, 2002. Available at: https://office.de.netcord.org/inventory.gif. Accessed September 27, 2002.
3. Barker JN, Krepski TP, DeFor T, et al.: Searching for unrelated donor hematopoietic stem cell grafts: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002, 8:257-260.
4. Gluckman E, Rocha V, Boyer-Chammard A, et al.: Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997, 337:373-381.
5. Wagner JE, Kurtzberg J: Allogeneic umbilical cord blood transplantation. In Cellular Characteristics of Cord Blood Transplantation. Edited by Broxmeyer HE. Bethesda: AABB Press; 1998:113-146.
6. Gluckman E: Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000, 28:1197-1205.
7. Rocha V, Wagner JE, Sobocinski KA, et al.: Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000, 342:1846-1854.
8. Gluckman E, Rocha V, Chevret S: Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2001, 5:87-99.
9. Rubinstein P, Carrier C, Scaradavou A, et al.: Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
10. Rubinstein P, Stevens CE: Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results. Baillieres Best Pract Res Clin Haematol 2000, 13:565-584.
11. Ohnuma K, Isoyama K, Nishihira H: Cord blood transplantation from HLAmismatched unrelated donors. Leuk Lymphoma 2002, 43:1029-1043.
12. Kurtzberg J, Laughlin M, Graham ML, et al.: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996, 335:157-166.
13. Wagner JE, Barker JN, DeFor TE, et al.: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
14. Yu LC, Wall DA, Sandler E, et al.: Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium. Pediatr Hematol Oncol 2001, 18:235-245.
15. Sierra J, Storer B, Hansen A, et al.: Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997, 89:4226-4235.
16. Migliaccio AR, Adamson JW, Stevens CE, et al.: Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000, 96:2717-2722.
17. Stevens CE, Gladstone J, Taylor PE, et al.: Placental/umbilical cord blood for unrelated donor bone marrow reconstitution: relevance of nucleated red blood cells. Blood 2002, 100:2662-2664.
18. Rocha V, Cornish J, Sievers E, et al.: Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97:2962-2971.
19. Barker JN, Davies SM, DeFor T, et al.: Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001, 97:2957-2961.
20. Sanz MA, Sanz GF: Unrelated umbilical cord blood transplantation in adults. Leukemia 2002 2002;16:1984-1991.
21. Laporte J-P, Gorin N-C, Rubinstein P, et al.: Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N Engl J Med 1996, 35:167-170.
22. Cairo MS, Wagner JE: Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997, 90:4665-4678.
23. Laughlin MJ, Barker J, Bambach B, et al.: Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001, 344:1815-1822.
24. Sanz GF, Saavedra S, Planelles D, et al.: Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001, 98:2332-2338.
25. Iseki T, Ooi J, Tomonari A, et al.: Unrelated cord blood transplantation in adult patients with hematological malignancy: a single institution experience. Blood 2001, 98(suppl 1):665a
26. Rocha V, Arcese W, Sanz G, et al.: Prognostic factors of outcome after unrelated cord blood transplant in adults with hematologic malignancies. Blood 2000, 96(suppl 1):587a.
27. Sanz GF, Saavedra S, Jimenez C, et al.: Unrelated donor cord-blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution. Bone Marrow Transplant 2001, 27:693-701.
28. Ooi J, Iseki T, Nagayama H, et al.: Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. Br J Haematol 2001, 114:834-836.
29. Urbano-Ispizua A, Schmitz N, de Witte T, et al.: Allogeneic and autologous transplantation for hematological disease, solid tumors and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002, 29:639-646.
30. Davies SM, Kollman C, Anasetti C, et al.: Engraftment and survival after unrelated donor bone marrow transplantation: a report from the National Marrow Donor Program. Blood 2000, 96:4096-4102.
31. Hansen JA, Gooley TA, Martin PJ, et al.: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998, 338:962-968.
32. McGlave PB, Shu XO, Wen W, et al.: Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years experience of the National Marrow Donor Program. Blood 2000, 95:2219-2225.
33. Ooi J, Iseki T, Takahashi S, et al.: A clinical comparison of unrelated cord blood transplantation and unrelated bone marrow transplantation for adult patients with acute leukaemia in complete remission. Br J Haematol 2002, 118:140-143.
34. Niehues T, Rocha V, Filipovich A, et al.: Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children-a Eurocord analysis. Br J Haematol 2001, 114:42-48.
35. Ballen K, Broxmeyer HE, McCullough J, et al.: Current status of cord blood banking and transplantation in the United States and Europe. Biol Blood Marrow Transplant 2001, 7:635-645.
36. Tanavde VM, Malehorn MT, Lumkul R, et al.: Human stem-progenitor cells form neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002, 30:816-823.
37. Pollok KE, van Der Loo JC, Cooper RJ, et al.: Differential transduction efficiency of SCID-repopulating derived from umbilical cord blood and granulocyte colony-stimulating factor-mobilized peripheral blood. Hum Gene Ther 2001, 20:2095-2108.
38. Guenechea G, Segovia JC, Albella B, et al.: Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood 1999, 93:1097-1105.
39. Lewis ID, Almeida-Porara G, Du J, et al.: Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001, 97:3441-3449.
40. McNiece IK, Almeida-Porara G, Shpall EJ, et al.: Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol 2002, 30:612-616.
41. Dening-Kendall PA, Evely R, Singha S, et al.: In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells. Br J Haematol 2002, 116:218-228.
42. Su RJ, Zhang XB, Li K, et al.: Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells. Br J Haematol 2002, 117:735-746.
43. Ramirez M, Segovia JC, Benet I, et al.: Ex vivo expansion of umbilical cord blood (UCB) CD34(+) cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins. Br J Haematol 2001, 115:213-221.
44. Shpall EJ, Quiones R, Giller R, et al.: Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8:368-376.
45. Pick M, Eldor A, Grisaru D, et al.: Ex vivo expansion of megakaryocyte progenitors from cryopreserved umbilical cord blood: a potential source ofmegakaryocytes for transplantation. Exp Hematol 2002, 30:1079-1087.
46. Robinson KL, Ayello J, Hughes R, et al.: Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti CD3, and IL-7: potential for adoptive immunotherapy post-umbilical cord blood transplantation. Exp Hematol 2002, 30:245-251.
47. Barker JN, Weisdorf DJ, Wagner JE: Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001, 344:1870-1871.
48. Barker JN, Weisdorf DJ, DeFor TE, et al.: Impact of multiple unit unrelated donor umbilical cord blood transplantation in adults: preliminary analysis of safety and efficacy. Blood 2001, 98(Suppl 1):666a.
49. Gryn J, Harris DT, Shadduck RK, et al.: Multiple unmatched umbilical cord units (MUCs) for adult allogeneic transplantation. Blood 2001, 98(suppl 1): 666a.
50. Fernandez MN, Regidor C, Cabrera R, et al.: Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms. Bone Marrow Transplant 2001, 28:355-363.
51. Lau FY, Wong R, Chui CH, et al.: Successful engraftment in two adult patients with severe aplastic anemia using nonmyeloablative conditioning followed by unrelated HLA-mismatched cord blood transplantation. J Hematother Stem Cell Res 2001, 10:309-311.
52. De Medeiros CR, Silva LM, Pasquini R: Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplant 2001, 28:110-112.
53. Rizzieri DA, Long GD, Vredenburgh JJ, et al.: Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. Blood 2001, 98:3486-3488.
54. Shibuya A, Kaneko I, Ishii S, et al.: Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia. Hematol 2002, 7:101-103.
55. Barker JN, DeFor TE, Repka TL, et al.: Unrelated donor umbilical cord blood transplantation after non-myeloablative conditioning in adults: rapid and complete donor chimerism. Blood 2001, 98(suppl 1):814a.
56. Moretta A, Maccario R, Fagioli F, et al.: Analysis of immune reconstitution in children undergoing cord blood transplantation Exp Hematol 2001, 29:371-379.
57. Talvensaari K, Clave E, Douay C, et al.: A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002, 99:1458-1464.
58. Klein AK, Patel DD, Gooding ME, et al.: T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001, 7:454-466.
59. Chao NJ, Liu CX, Rooney B, et al.: Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T cells. Biol Blood Marrow Transplant 2002, 8:249-256.
60. Volpi I, Perrucio K, Tosti A, et al.: Post grafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 2001, 97:2514-2521.
61. Barker JN, Martin PL, Coad JE, et al.: Low incidence of Epstein-Barr virusassociated posttransplantation lymphoproliferative disorders in 272 unrelated donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001, 7:395-399.
62. Sashihara J, Tonaka-Taya K, Tanaka S, et al.: High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002, 100:2005-2011.
63. Carvajal E, Verdeguer A, Fernandez JM, et al.: Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation. J Pediatr Hematol Oncol 2001, 23:626-628.
64. Chik KW, Chan PK, Li CK, et al.: Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children. Bone Marrow Transplant 2002, 29:991-994.
65. Zaia JA: Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation. CID 2002, 35:999-1004.